Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Hutson

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Biorxiv : the Preprint Server for Biology|November 14, 2023
Differentiation of hypervirulent and classical <i>Klebsiella pneumoniae</i> with acquired drug resistanceThomas A Russo, Cassandra L Alvarado, Connor J Davies, et al.
Alcohol (Fayetteville, N.Y.)|December 21, 2010
Alcohol consumption in relation to aberrant DNA methylation in breast tumorsMeng Hua Tao, Catalin Marian, Peter G Shields, et al.
Journal for Immunotherapy of Cancer|March 25, 2025
mTOR inhibition modulates vaccine-induced immune responses to generate memory T cells in patients with solid tumorsHenry G Withers, Junko Matsuzaki, Mark Long, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 10, 2018
Reduced-Intensity Conditioning with Fludarabine, Melphalan, and Total Body Irradiation for Allogeneic Hematopoietic Cell Transplantation: The Effect of Increasing Melphalan Dose on Underlying Disease and ToxicityGeorge L Chen, Theresa Hahn, Gregory E Wilding, et al.
Mbio|January 17, 2024
Differentiation of hypervirulent and classical <i>Klebsiella pneumoniae</i> with acquired drug resistanceThomas A Russo, Cassandra L Alvarado, Connor J Davies, et al.
Gynecologic Oncology|December 16, 2019
GOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patientsJay W Carlson, James Kauderer, Alan Hutson, et al.
BJU International|December 18, 2016
Development, validation and clinical application of Pelvic Lymphadenectomy Assessment and Completion Evaluation: intraoperative assessment of lymph node dissection after robot-assisted radical cystectomy for bladder cancerAhmed A Hussein, Nobuyuki Hinata, Shiva Dibaj, et al.
Gynecologic Oncology|October 28, 2020
GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and functionJeanne Carter, Helen Q Huang, Jane Armer, et al.
Blood Advances|November 14, 2022
Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCLPallawi Torka, Adrienne Groman, Jerry Wong, et al.
Gynecologic Oncology|November 5, 2019
GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE)Jeanne Carter, Helen Q Huang, Jane Armer, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Biorxiv : the Preprint Server for Biology|November 14, 2023
Differentiation of hypervirulent and classical <i>Klebsiella pneumoniae</i> with acquired drug resistanceThomas A Russo, Cassandra L Alvarado, Connor J Davies, et al.
Alcohol (Fayetteville, N.Y.)|December 21, 2010
Alcohol consumption in relation to aberrant DNA methylation in breast tumorsMeng Hua Tao, Catalin Marian, Peter G Shields, et al.
Journal for Immunotherapy of Cancer|March 25, 2025
mTOR inhibition modulates vaccine-induced immune responses to generate memory T cells in patients with solid tumorsHenry G Withers, Junko Matsuzaki, Mark Long, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 10, 2018
Reduced-Intensity Conditioning with Fludarabine, Melphalan, and Total Body Irradiation for Allogeneic Hematopoietic Cell Transplantation: The Effect of Increasing Melphalan Dose on Underlying Disease and ToxicityGeorge L Chen, Theresa Hahn, Gregory E Wilding, et al.
Mbio|January 17, 2024
Differentiation of hypervirulent and classical <i>Klebsiella pneumoniae</i> with acquired drug resistanceThomas A Russo, Cassandra L Alvarado, Connor J Davies, et al.
Gynecologic Oncology|December 16, 2019
GOG 244-The lymphedema and gynecologic cancer (LEG) study: Incidence and risk factors in newly diagnosed patientsJay W Carlson, James Kauderer, Alan Hutson, et al.
BJU International|December 18, 2016
Development, validation and clinical application of Pelvic Lymphadenectomy Assessment and Completion Evaluation: intraoperative assessment of lymph node dissection after robot-assisted radical cystectomy for bladder cancerAhmed A Hussein, Nobuyuki Hinata, Shiva Dibaj, et al.
Gynecologic Oncology|October 28, 2020
GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and functionJeanne Carter, Helen Q Huang, Jane Armer, et al.
Blood Advances|November 14, 2022
Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCLPallawi Torka, Adrienne Groman, Jerry Wong, et al.
Gynecologic Oncology|November 5, 2019
GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE)Jeanne Carter, Helen Q Huang, Jane Armer, et al.
Pageof 10